The mission of Spectrum, the CTSA-supported independent research center at Stanford, is to transform the academic enterprise to optimally support clinical and translational research and education (CTRE). Spectrum's programs are designed to extend from the earliest phase of basic discovery to final implementation of these discoveries in the population. The ultimate goals of our efforts are to streamline the translation of basic innovations into practical solutions that maintain and improve human health, and to educate the next generation of CTR leaders. In the next five years. Spectrum will leverage institutional strengths to nurture our entrepreneurial researchers to efficiently transfer discoveries from the laboratory to the bedside and into the community. The CTSA will provide critical resources, services and educational opportunities to ensure progress toward this mission.
The specific aims of Spectrum are: 1) Educate the next generation of investigators with the multidisciplinary skills required to conduct cutting- edge clinical and translational research to meet the opportunities and challenges of medicine in the 21st century. Spectrum will facilitate the transformation of medical research training from a narrow focus on discipline-restricted expertise to a more interdisciplinary team approach where trainees become conversant in the language, processes and tools used across the full extent of the translational pipeline (T1-T4). 2) Create an institutional home conducive to efficiently translating the most innovative discoveries made by our basic, translational and clinical scientists into products and processes that directly improve human health and well-being. Spectrum will provide the institutional environment to identify and then support those discoveries that are most ready for translation. 3) Develop and implement CTRE resources and services to accelerate the translation of discoveries into better human health, while simultaneously reducing operating costs. Spectrum will ensure that investigators receive the necessary clinical trial, informatics, statistics, regulatory, ethics and administrative support to maximize their research productivity, and optimize the participation of diverse populations.

Public Health Relevance

The mission of Spectrum, Stanford's CTSA-supported center, is to transform the enterprise to best support discovery, innovation and education in clinical and translational research across the university. Spectrum's programs extend from the earliest phase of basic discovery to final implementation in the population, with an ultimate goal of strengthening healthcare and improving cost efficiencies.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR001085-02
Application #
8743340
Study Section
Special Emphasis Panel (ZAI1-PTM-C (S2))
Program Officer
Wilson, Todd
Project Start
2013-09-26
Project End
2018-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
2
Fiscal Year
2014
Total Cost
$8,460,470
Indirect Cost
$2,980,697
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Nizar, Jonathan M; Shepard, Blythe D; Vo, Vianna T et al. (2018) Renal tubule insulin receptor modestly promotes elevated blood pressure and markedly stimulates glucose reabsorption. JCI Insight 3:
Sellers, Zachary M; MacIsaac, Donna; Yu, Helen et al. (2018) Nationwide Trends in Acute and Chronic Pancreatitis Among Privately Insured Children and Non-Elderly Adults in the United States, 2007-2014. Gastroenterology 155:469-478.e1
Baxter, Ryan M; Kong, Daniel S; Garcia-Perez, Josselyn E et al. (2018) Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry. J Vis Exp :
Chen, Matthew C; Ball, Robyn L; Yang, Lingyao et al. (2018) Deep Learning to Classify Radiology Free-Text Reports. Radiology 286:845-852
Park, K T; Sceats, L; Dehghan, M et al. (2018) Risk of post-operative surgical site infections after vedolizumab vs anti-tumour necrosis factor therapy: a propensity score matching analysis in inflammatory bowel disease. Aliment Pharmacol Ther 48:340-346
Knowles, Juliet K; Santoro, Jonathan D; Porter, Brenda E et al. (2018) Refractory focal epilepsy in a paediatric patient with primary familial brain calcification. Seizure 56:50-52
Butwick, Alexander J; Abreo, Anisha; Bateman, Brian T et al. (2018) Effect of Maternal Body Mass Index on Postpartum Hemorrhage. Anesthesiology 128:774-783
Abdolazimi, Yassan; Zhao, Zhengshan; Lee, Sooyeon et al. (2018) CC-401 Promotes ?-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition. Endocrinology 159:3143-3157
Hopkins, Joseph; Fassiotto, Magali; Ku, Manwai Candy et al. (2018) Designing a physician leadership development program based on effective models of physician education. Health Care Manage Rev 43:293-302
Vranas, Kelly C; Jopling, Jeffrey K; Scott, Jennifer Y et al. (2018) The Association of ICU Acuity With Outcomes of Patients at Low Risk of Dying. Crit Care Med 46:347-353

Showing the most recent 10 out of 406 publications